<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">31547098</PMID>
      <DateRevised>
        <Year>2020</Year>
        <Month>09</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Print">2077-0383</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>8</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical medicine</Title>
          <ISOAbbreviation>J Clin Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Brain-Immune Alterations and Mitochondrial Dysfunctions in a Mouse Model of Paediatric Autoimmune Disorder Associated with Streptococcus: Exacerbation by Chronic Psychosocial Stress.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">1514</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm8101514</ELocationID>
        <Abstract>
          <AbstractText>Adverse psychosocial experiences have been shown to modulate individual responses to immune challenges and affect mitochondrial functions. The aim of this study was to investigate inflammation and immune responses as well as mitochondrial bioenergetics in an experimental model of Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus (PANDAS). Starting in adolescence (postnatal day 28), male SJL/J mice were exposed to five injections (interspaced by two weeks) with Group-A beta-haemolytic streptococcus (GAS) homogenate. Mice were exposed to chronic psychosocial stress, in the form of protracted visual exposure to an aggressive conspecific, for four weeks. Our results indicate that psychosocial stress exacerbated individual response to GAS administrations whereby mice exposed to both treatments exhibited altered cytokine and immune-related enzyme expression in the hippocampus and hypothalamus. Additionally, they showed impaired mitochondrial respiratory chain complexes IV and V, and reduced adenosine triphosphate (ATP) production by mitochondria and ATP content. These brain abnormalities, observed in GAS-Stress mice, were associated with blunted titers of plasma corticosterone. Present data support the hypothesis that challenging environmental conditions, in terms of chronic psychosocial stress, may exacerbate the long-term consequences of exposure to GAS processes through the promotion of central immunomodulatory and oxidative stress.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ajmone-Cat</LastName>
            <ForeName>Maria Antonietta</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>National Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy. mariaantonietta.ajmone-cat@iss.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Spinello</LastName>
            <ForeName>Chiara</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy. chiara.spnll@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Mechanical and Aerospace Engineering, New York University Tandon School of Engineering, Brooklyn, NY 11201, USA. chiara.spnll@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Valenti</LastName>
            <ForeName>Daniela</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Council of Research, Via Giovanni Amendola 122/O - 70126 Bari, Italy. d.valenti@ibiom.cnr.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Franchi</LastName>
            <ForeName>Francesca</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy. francesca.franchi@iss.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Macrì</LastName>
            <ForeName>Simone</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy. simone.macri@iss.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vacca</LastName>
            <ForeName>Rosa Anna</ForeName>
            <Initials>RA</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies, National Council of Research, Via Giovanni Amendola 122/O - 70126 Bari, Italy. r.vacca@ibiom.cnr.it.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Laviola</LastName>
            <ForeName>Giovanni</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Centre for Behavioural Sciences and Mental Health, Istituto Superiore di Sanità, Viale Regina Elena, 299, I-00161 Rome, Italy. giovanni.laviola@iss.it.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>09</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Med</MedlineTA>
        <NlmUniqueID>101606588</NlmUniqueID>
        <ISSNLinking>2077-0383</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adverse emotional experience</Keyword>
        <Keyword MajorTopicYN="N">Animal Models</Keyword>
        <Keyword MajorTopicYN="N">Immunity</Keyword>
        <Keyword MajorTopicYN="N">Mitochondrial bioenergetics</Keyword>
        <Keyword MajorTopicYN="N">Neuroinflammation</Keyword>
        <Keyword MajorTopicYN="N">PANDAS</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>9</Month>
          <Day>25</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31547098</ArticleId>
        <ArticleId IdType="pmc">PMC6833026</ArticleId>
        <ArticleId IdType="doi">10.3390/jcm8101514</ArticleId>
        <ArticleId IdType="pii">jcm8101514</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Benros M.E., Waltoft B.L., Nordentoft M., Østergaard S.D., Eaton W.W., Krogh J., Mortensen P.B. Autoimmune Diseases and Severe Infections as Risk Factors for Mood Disorders. JAMA Psychiatry. 2013;70:812. doi: 10.1001/jamapsychiatry.2013.1111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2013.1111</ArticleId>
            <ArticleId IdType="pubmed">23760347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Köhler-Forsberg O., Petersen L., Gasse C., Mortensen P.B., Dalsgaard S., Yolken R.H., Mors O., Benros M.E. A Nationwide Study in Denmark of the Association between Treated Infections and the Subsequent Risk of Treated Mental Disorders in Children and Adolescents. JAMA Psychiatry. 2018 doi: 10.1001/jamapsychiatry.2018.3428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2018.3428</ArticleId>
            <ArticleId IdType="pmc">PMC6439826</ArticleId>
            <ArticleId IdType="pubmed">30516814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sperner-Unterweger B. Immunological aetiology of major psychiatric disorders: Evidence and therapeutic implications. Drugs. 2005;65:1493–1520. doi: 10.2165/00003495-200565110-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2165/00003495-200565110-00004</ArticleId>
            <ArticleId IdType="pubmed">16033289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tylee D.S., Sun J., Hess J.L., Tahir M.A., Sharma E., Malik R., Worrall B.B., Levine A.J., Martinson J.J., Nejentsev S., et al.  Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2018;177:641–657. doi: 10.1002/ajmg.b.32652.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.b.32652</ArticleId>
            <ArticleId IdType="pmc">PMC6230304</ArticleId>
            <ArticleId IdType="pubmed">30325587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khandaker G.M., Dantzer R., Jones P.B. Immunopsychiatry: Important facts. Psychol. Med. 2017;47:2229–2237. doi: 10.1017/S0033291717000745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S0033291717000745</ArticleId>
            <ArticleId IdType="pmc">PMC5817424</ArticleId>
            <ArticleId IdType="pubmed">28418288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levin M.C., Lee S.M., Kalume F., Morcos Y., Dohan F.C., Hasty K.A., Callaway J.C., Zunt J., Desiderio D.M., Stuart J.M. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat. Med. 2002;8:509–513. doi: 10.1038/nm0502-509.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm0502-509</ArticleId>
            <ArticleId IdType="pmc">PMC2703733</ArticleId>
            <ArticleId IdType="pubmed">11984596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brimberg L., Benhar I., Mascaro-Blanco A., Alvarez K., Lotan D., Winter C., Klein J., Moses A.E., Somnier F.E., Leckman J.F., et al.  Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: A novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology. 2012;37:2076–2087. doi: 10.1038/npp.2012.56.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/npp.2012.56</ArticleId>
            <ArticleId IdType="pmc">PMC3398718</ArticleId>
            <ArticleId IdType="pubmed">22534626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Garvey M.A., Giedd J., Swedo S.E. PANDAS: The search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J. Child Neurol. 1998;13:413–423. doi: 10.1177/088307389801300901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/088307389801300901</ArticleId>
            <ArticleId IdType="pubmed">9733286</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman K.L., Hornig M., Yaddanapudi K., Jabado O., Lipkin W.I. A murine model for neuropsychiatric disorders associated with group A beta-hemolytic streptococcal infection. J. Neurosci. 2004;24:1780–1791. doi: 10.1523/JNEUROSCI.0887-03.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.0887-03.2004</ArticleId>
            <ArticleId IdType="pmc">PMC6730451</ArticleId>
            <ArticleId IdType="pubmed">14973249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Snider L.A., Swedo S.E. PANDAS: Current status and directions for research. Mol. Psychiatry. 2004;9:900–907. doi: 10.1038/sj.mp.4001542.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.mp.4001542</ArticleId>
            <ArticleId IdType="pubmed">15241433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Leonard H.L., Rapoport J.L. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: Separating fact from fiction. Pediatrics. 2004;113:907–911. doi: 10.1542/peds.113.4.907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.113.4.907</ArticleId>
            <ArticleId IdType="pubmed">15060242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yaddanapudi K., Hornig M., Serge R., De Miranda J., Baghban A., Villar G., Lipkin W.I. Passive transfer of streptococcus-induced antibodies reproduces behavioral disturbances in a mouse model of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection. Mol. Psychiatry. 2010;15:712–726. doi: 10.1038/mp.2009.77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/mp.2009.77</ArticleId>
            <ArticleId IdType="pubmed">19668249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoekstra P.J., Dietrich A., Edwards M.J., Elamin I., Martino D. Environmental factors in Tourette syndrome. Neurosci. Biobehav. Rev. 2013;37:1040–1049. doi: 10.1016/j.neubiorev.2012.10.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2012.10.010</ArticleId>
            <ArticleId IdType="pubmed">23092654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonard H.L., Swedo S.E. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) Int. J. Neuropsychopharmacol. 2001;4:191–198. doi: 10.1017/S1461145701002371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1461145701002371</ArticleId>
            <ArticleId IdType="pubmed">11466169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cardona F., Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J. Pediatr. 2001;138:71–75. doi: 10.1067/mpd.2001.110325.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1067/mpd.2001.110325</ArticleId>
            <ArticleId IdType="pubmed">11148515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rizzo R., Gulisano M., Pavone P., Fogliani F., Robertson M.M. Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: Controlled cross-sectional study. J. Child Neurol. 2006;21:747–753. doi: 10.1177/08830738060210091001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/08830738060210091001</ArticleId>
            <ArticleId IdType="pubmed">16970879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orlovska S., Vestergaard C.H., Bech B.H., Nordentoft M., Vestergaard M., Benros M.E. Association of Streptococcal Throat Infection with Mental Disorders: Testing Key Aspects of the PANDAS Hypothesis in a Nationwide Study. JAMA Psychiatry. 2017;74:740–746. doi: 10.1001/jamapsychiatry.2017.0995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapsychiatry.2017.0995</ArticleId>
            <ArticleId IdType="pmc">PMC5710247</ArticleId>
            <ArticleId IdType="pubmed">28538981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macrì S., Ceci C., Onori M.P., Invernizzi R.W., Bartolini E., Altabella L., Canese R., Imperi M., Orefici G., Creti R., et al.  Mice repeatedly exposed to Group-A β-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating, and immune activation in rostral diencephalon. Sci. Rep. 2015;5:13257. doi: 10.1038/srep13257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/srep13257</ArticleId>
            <ArticleId IdType="pmc">PMC4548234</ArticleId>
            <ArticleId IdType="pubmed">26304458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macrì S., Spinello C., Widomska J., Magliozzi R., Poelmans G., Invernizzi R.W., Creti R., Roessner V., Bartolini E., Margarit I., et al.  Neonatal corticosterone mitigates autoimmune neuropsychiatric disorders associated with streptococcus in mice. Sci. Rep. 2018;8:10188. doi: 10.1038/s41598-018-28372-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-28372-3</ArticleId>
            <ArticleId IdType="pmc">PMC6033871</ArticleId>
            <ArticleId IdType="pubmed">29976948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conelea C.A., Woods D.W. The influence of contextual factors on tic expression in Tourette’s syndrome: A review. J. Psychosom. Res. 2008;65:487–496. doi: 10.1016/j.jpsychores.2008.04.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpsychores.2008.04.010</ArticleId>
            <ArticleId IdType="pubmed">18940379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buse J., Kirschbaum C., Leckman J.F., Münchau A., Roessner V. The Modulating Role of Stress in the Onset and Course of Tourette’s Syndrome: A Review. Behav. Modif. 2014;38:184–216. doi: 10.1177/0145445514522056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0145445514522056</ArticleId>
            <ArticleId IdType="pubmed">24516255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Godar S.C., Bortolato M. What makes you tic? Translational approaches to study the role of stress and contextual triggers in Tourette syndrome. Neurosci. Biobehav. Rev. 2017;76:123–133. doi: 10.1016/j.neubiorev.2016.10.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2016.10.003</ArticleId>
            <ArticleId IdType="pmc">PMC5403589</ArticleId>
            <ArticleId IdType="pubmed">27939782</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leckman J.F. Tourette’s syndrome. Lancet. 2002;360:1577–1586. doi: 10.1016/S0140-6736(02)11526-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(02)11526-1</ArticleId>
            <ArticleId IdType="pubmed">12443611</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Motlagh M.G., Katsovich L., Thompson N., Lin H., Kim Y.-S., Scahill L., Lombroso P.J., King R.A., Peterson B.S., Leckman J.F. Severe psychosocial stress and heavy cigarette smoking during pregnancy: An examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur. Child. Adolesc. Psychiatry. 2010;19:755–764. doi: 10.1007/s00787-010-0115-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00787-010-0115-7</ArticleId>
            <ArticleId IdType="pmc">PMC3932440</ArticleId>
            <ArticleId IdType="pubmed">20532931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saccomani L., Fabiana V., Manuela B., Giambattista R. Tourette syndrome and chronic tics in a sample of children and adolescents. Brain Dev. 2005;27:349–352. doi: 10.1016/j.braindev.2004.09.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.braindev.2004.09.007</ArticleId>
            <ArticleId IdType="pubmed">16023550</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conelea C.A., Woods D.W., Brandt B.C. The impact of a stress induction task on tic frequencies in youth with Tourette Syndrome. Behav. Res. Ther. 2011;49:492–497. doi: 10.1016/j.brat.2011.05.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brat.2011.05.006</ArticleId>
            <ArticleId IdType="pubmed">21658680</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin H., Katsovich L., Ghebremichael M., Findley D.B., Grantz H., Lombroso P.J., King R.A., Zhang H., Leckman J.F. Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorder. J. Child Psychol. Psychiatry. 2007;48:157–166. doi: 10.1111/j.1469-7610.2006.01687.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-7610.2006.01687.x</ArticleId>
            <ArticleId IdType="pmc">PMC3073143</ArticleId>
            <ArticleId IdType="pubmed">17300554</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bateson P., Barker D., Clutton-Brock T., Deb D., D’Udine B., Foley R.A., Gluckman P., Godfrey K., Kirkwood T., Lahr M.M., et al.  Developmental plasticity and human health. Nature. 2004;430:419–421. doi: 10.1038/nature02725.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature02725</ArticleId>
            <ArticleId IdType="pubmed">15269759</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bale T.L., Epperson C.N. Sex differences and stress across the lifespan. Nat. Neurosci. 2015;18:1413–1420. doi: 10.1038/nn.4112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nn.4112</ArticleId>
            <ArticleId IdType="pmc">PMC4620712</ArticleId>
            <ArticleId IdType="pubmed">26404716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A. Social stress, immune functions and disease in rodents. Front. Neuroendocrinol. 2007;28:28–49. doi: 10.1016/j.yfrne.2007.02.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yfrne.2007.02.001</ArticleId>
            <ArticleId IdType="pubmed">17379284</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krishnan V., Han M.-H., Graham D.L., Berton O., Renthal W., Russo S.J., LaPlant Q., Graham A., Lutter M., Lagace D.C., et al.  Molecular Adaptations Underlying Susceptibility and Resistance to Social Defeat in Brain Reward Regions. Cell. 2007;131:391–404. doi: 10.1016/j.cell.2007.09.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2007.09.018</ArticleId>
            <ArticleId IdType="pubmed">17956738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lassance-Soares R.M., Sood S., Chakraborty N., Jhamnani S., Aghili N., Nashin H., Hammamieh R., Jett M., Epstein S.E., Burnett M.S. Chronic stress impairs collateral blood flow recovery in aged mice. J. Cardiovasc. Transl. Res. 2014;7:749–755. doi: 10.1007/s12265-014-9592-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12265-014-9592-2</ArticleId>
            <ArticleId IdType="pubmed">25315467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McEwen B.S. Physiology and neurobiology of stress and adaptation: Central role of the brain. Physiol. Rev. 2007;87:873–904. doi: 10.1152/physrev.00041.2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/physrev.00041.2006</ArticleId>
            <ArticleId IdType="pubmed">17615391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pryce C.R., Fuchs E. Chronic psychosocial stressors in adulthood: Studies in mice, rats and tree shrews. Neurobiol. Stress. 2017;6:94–103. doi: 10.1016/j.ynstr.2016.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ynstr.2016.10.001</ArticleId>
            <ArticleId IdType="pmc">PMC5314423</ArticleId>
            <ArticleId IdType="pubmed">28229112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scharf S.H., Sterlemann V., Liebl C., Müller M.B., Schmidt M.V. Chronic social stress during adolescence: Interplay of paroxetine treatment and ageing. Neuropharmacology. 2013;72:38–46. doi: 10.1016/j.neuropharm.2013.03.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2013.03.035</ArticleId>
            <ArticleId IdType="pubmed">23602985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goshen I., Yirmiya R. Interleukin-1 (IL-1): A central regulator of stress responses. Front. Neuroendocrinol. 2009;30:30–45. doi: 10.1016/j.yfrne.2008.10.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yfrne.2008.10.001</ArticleId>
            <ArticleId IdType="pubmed">19017533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005;25:9275–9284. doi: 10.1523/JNEUROSCI.2614-05.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.2614-05.2005</ArticleId>
            <ArticleId IdType="pmc">PMC6725757</ArticleId>
            <ArticleId IdType="pubmed">16207887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frank M.G., Weber M.D., Watkins L.R., Maier S.F. Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disorders. Neurobiol. Stress. 2016;4:62–70. doi: 10.1016/j.ynstr.2015.12.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ynstr.2015.12.004</ArticleId>
            <ArticleId IdType="pmc">PMC5146200</ArticleId>
            <ArticleId IdType="pubmed">27981190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johnson J., O’Connor K., Watkins L., Maier S. The role of IL-1β in stress-induced sensitization of proinflammatory cytokine and corticosterone responses. Neuroscience. 2004;127:569–577. doi: 10.1016/j.neuroscience.2004.05.046.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2004.05.046</ArticleId>
            <ArticleId IdType="pubmed">15283957</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry V.H., Newman T.A., Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat. Rev. Neurosci. 2003;4:103–112. doi: 10.1038/nrn1032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn1032</ArticleId>
            <ArticleId IdType="pubmed">12563281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barron H., Hafizi S., Andreazza A., Mizrahi R. Neuroinflammation and Oxidative Stress in Psychosis and Psychosis Risk. Int. J. Mol. Sci. 2017;18:651.  doi: 10.3390/ijms18030651.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms18030651</ArticleId>
            <ArticleId IdType="pmc">PMC5372663</ArticleId>
            <ArticleId IdType="pubmed">28304340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pei L., Wallace D.C. Mitochondrial Etiology of Neuropsychiatric Disorders. Biol. Psychiatry. 2018;83:722–730. doi: 10.1016/j.biopsych.2017.11.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.biopsych.2017.11.018</ArticleId>
            <ArticleId IdType="pmc">PMC5891364</ArticleId>
            <ArticleId IdType="pubmed">29290371</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valenti D., de Bari L., De Filippis B., Henrion-Caude A., Vacca R.A. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: An overview of Down syndrome, autism, Fragile X and Rett syndrome. Pt 2Neurosci. Biobehav. Rev. 2014;46:202–217. doi: 10.1016/j.neubiorev.2014.01.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2014.01.012</ArticleId>
            <ArticleId IdType="pubmed">24548784</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vacca R.A., Bawari S., Valenti D., Tewari D., Nabavi S.F., Shirooie S., Sah A.N., Volpicella M., Braidy N., Nabavi S.M. Down syndrome: Neurobiological alterations and therapeutic targets. Neurosci. Biobehav. Rev. 2019;98:234–255. doi: 10.1016/j.neubiorev.2019.01.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neubiorev.2019.01.001</ArticleId>
            <ArticleId IdType="pubmed">30615933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valenti D., Braidy N., De Rasmo D., Signorile A., Rossi L., Atanasov A.G., Volpicella M., Henrion-Caude A., Nabavi S.M., Vacca R.A. Mitochondria as pharmacological targets in Down syndrome. Free Radic. Biol. Med. 2018;114:69–83. doi: 10.1016/j.freeradbiomed.2017.08.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.08.014</ArticleId>
            <ArticleId IdType="pubmed">28838841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris G., Stubbs B., Köhler C.A., Walder K., Slyepchenko A., Berk M., Carvalho A.F. The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med. Rev. 2018;41:255–265. doi: 10.1016/j.smrv.2018.03.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.smrv.2018.03.007</ArticleId>
            <ArticleId IdType="pubmed">29759891</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Simone R., Ajmone-Cat M.A., Pandolfi M., Bernardo A., De Nuccio C., Minghetti L., Visentin S. The mitochondrial uncoupling protein-2 is a master regulator of both M1 and M2 microglial responses. J. Neurochem. 2015;135:147–156. doi: 10.1111/jnc.13244.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.13244</ArticleId>
            <ArticleId IdType="pubmed">26173855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferger A.I., Campanelli L., Reimer V., Muth K.N., Merdian I., Ludolph A.C., Witting A. Effects of mitochondrial dysfunction on the immunological properties of microglia. J. Neuroinflamm. 2010;7:45. doi: 10.1186/1742-2094-7-45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1742-2094-7-45</ArticleId>
            <ArticleId IdType="pmc">PMC2925359</ArticleId>
            <ArticleId IdType="pubmed">20701773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C., Zhou H.-M. The Role of Manganese Superoxide Dismutase in Inflammation Defense. Enzym. Res. 2011;2011:387176. doi: 10.4061/2011/387176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4061/2011/387176</ArticleId>
            <ArticleId IdType="pmc">PMC3185262</ArticleId>
            <ArticleId IdType="pubmed">21977313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Piantadosi C.A., Suliman H.B. Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes. Biochim. Biophys. Acta Gen. Subj. 2012;1820:532–541. doi: 10.1016/j.bbagen.2012.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagen.2012.01.003</ArticleId>
            <ArticleId IdType="pmc">PMC3307899</ArticleId>
            <ArticleId IdType="pubmed">22265687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim E.K., Kwon J.-E., Lee S.-Y., Lee E.-J., Kim D.S., Moon S.-J., Lee J., Kwok S.-K., Park S.-H., Cho M.-L. IL-17-mediated mitochondrial dysfunction impairs apoptosis in rheumatoid arthritis synovial fibroblasts through activation of autophagy. Cell Death Dis. 2017;8:e2565. doi: 10.1038/cddis.2016.490.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cddis.2016.490</ArticleId>
            <ArticleId IdType="pmc">PMC5386390</ArticleId>
            <ArticleId IdType="pubmed">28102843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Flies D.B., Chen L. A simple and rapid vortex method for preparing antigen/adjuvant emulsions for immunization. J. Immunol. Methods. 2003;276:239–242. doi: 10.1016/S0022-1759(03)00081-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-1759(03)00081-4</ArticleId>
            <ArticleId IdType="pubmed">12738377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A., Cabassi A., Govoni P., Ceresini G., Cero C., Berra D., Dadomo H., Franceschini P., Dell’Omo G., Parmigiani S., et al.  Metabolic consequences and vulnerability to diet-induced obesity in male mice under chronic social stress. PLoS ONE. 2009;4:e4331.  doi: 10.1371/journal.pone.0004331.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0004331</ArticleId>
            <ArticleId IdType="pmc">PMC2628728</ArticleId>
            <ArticleId IdType="pubmed">19180229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanghez V., Razzoli M., Carobbio S., Campbell M., McCallum J., Cero C., Ceresini G., Cabassi A., Govoni P., Franceschini P., et al.  Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the Metabolic Syndrome. Psychoneuroendocrinology. 2013;38:2933–2942. doi: 10.1016/j.psyneuen.2013.07.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2013.07.022</ArticleId>
            <ArticleId IdType="pubmed">24060458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A., Carola V., Pascucci T., Puglisi-Allegra S., Cabib S., Lesch K.-P., Parmigiani S., Palanza P., Gross C. Increased vulnerability to psychosocial stress in heterozygous serotonin transporter knockout mice. Dis. Model. Mech. 2010;3:459–470. doi: 10.1242/dmm.004614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/dmm.004614</ArticleId>
            <ArticleId IdType="pubmed">20371729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dadomo H., Sanghez V., Di Cristo L., Lori A., Ceresini G., Malinge I., Parmigiani S., Palanza P., Sheardown M., Bartolomucci A. Vulnerability to chronic subordination stress-induced depression-like disorders in adult 129SvEv male mice. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2011;35:1461–1471. doi: 10.1016/j.pnpbp.2010.11.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pnpbp.2010.11.016</ArticleId>
            <ArticleId IdType="pubmed">21093519</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoratto F., Sbriccoli M., Martinelli A., Glennon J.C., Macrì S., Laviola G. Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness. Neuropharmacology. 2018;143:250–267. doi: 10.1016/j.neuropharm.2018.09.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2018.09.010</ArticleId>
            <ArticleId IdType="pubmed">30213592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A., Pederzani T., Sacerdote P., Panerai A.E., Parmigiani S., Palanza P. Behavioral and physiological characterization of male mice under chronic psychosocial stress. Psychoneuroendocrinology. 2004;29:899–910. doi: 10.1016/j.psyneuen.2003.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.psyneuen.2003.08.003</ArticleId>
            <ArticleId IdType="pubmed">15177705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macrì S., Pasquali P., Bonsignore L.T., Pieretti S., Cirulli F., Chiarotti F., Laviola G. Moderate neonatal stress decreases within-group variation in behavioral, immune and HPA responses in adult mice. PLoS ONE. 2007;2:e1015.  doi: 10.1371/journal.pone.0001015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0001015</ArticleId>
            <ArticleId IdType="pmc">PMC2000350</ArticleId>
            <ArticleId IdType="pubmed">17925863</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Macrì S., Granstrem O., Shumilina M., Antunes Gomes dos Santos F.J., Berry A., Saso L., Laviola G. Resilience and vulnerability are dose-dependently related to neonatal stressors in mice. Horm. Behav. 2009;56:391–398. doi: 10.1016/j.yhbeh.2009.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.yhbeh.2009.07.006</ArticleId>
            <ArticleId IdType="pubmed">19632235</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao W., Stalder T., Foley P., Rauh M., Deng H., Kirschbaum C. Quantitative analysis of steroid hormones in human hair using a column-switching LC-APCI-MS/MS assay. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2013;928:1–8. doi: 10.1016/j.jchromb.2013.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jchromb.2013.03.008</ArticleId>
            <ArticleId IdType="pubmed">23584040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valenti D., de Bari L., De Filippis B., Ricceri L., Vacca R.A. Preservation of mitochondrial functional integrity in mitochondria isolated from small cryopreserved mouse brain areas. Anal. Biochem. 2014;444:25–31. doi: 10.1016/j.ab.2013.08.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ab.2013.08.030</ArticleId>
            <ArticleId IdType="pubmed">24018341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Filippis B., Valenti D., Chiodi V., Ferrante A., de Bari L., Fiorentini C., Domenici M.R., Ricceri L., Vacca R.A., Fabbri A., et al.  Modulation of Rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome. Eur. Neuropsychopharmacol. 2015;25:889–901. doi: 10.1016/j.euroneuro.2015.03.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.euroneuro.2015.03.012</ArticleId>
            <ArticleId IdType="pubmed">25890884</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Manente A.G., Valenti D., Pinton G., Jithesh P.V., Daga A., Rossi L., Gray S.G., O’Byrne K.J., Fennell D.A., Vacca R.A., et al.  Estrogen receptor β activation impairs mitochondrial oxidative metabolism and affects malignant mesothelioma cell growth in vitro and in vivo. Oncogenesis. 2013;2:e72. doi: 10.1038/oncsis.2013.32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/oncsis.2013.32</ArticleId>
            <ArticleId IdType="pmc">PMC3816222</ArticleId>
            <ArticleId IdType="pubmed">24061575</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>De Filippis B., Valenti D., de Bari L., De Rasmo D., Musto M., Fabbri A., Ricceri L., Fiorentini C., Laviola G., Vacca R.A. Mitochondrial free radical overproduction due to respiratory chain impairment in the brain of a mouse model of Rett syndrome: Protective effect of CNF1. Free Radic. Biol. Med. 2015;83:167–177. doi: 10.1016/j.freeradbiomed.2015.02.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.02.014</ArticleId>
            <ArticleId IdType="pubmed">25708779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khan H.A. Bioluminometric assay of ATP in mouse brain: Determinant factors for enhanced test sensitivity. J. Biosci. 2003;28:379–382. doi: 10.1007/BF02705114.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF02705114</ArticleId>
            <ArticleId IdType="pubmed">12799486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vigli D., Rusconi L., Valenti D., La Montanara P., Cosentino L., Lacivita E., Leopoldo M., Amendola E., Gross C., Landsberger N., et al.  Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder. Neuropharmacology. 2019;144:104–114. doi: 10.1016/j.neuropharm.2018.10.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuropharm.2018.10.018</ArticleId>
            <ArticleId IdType="pubmed">30326240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deacon R.M.J., Rawlins J.N.P. T-maze alternation in the rodent. Nat. Protoc. 2006;1:7–12. doi: 10.1038/nprot.2006.2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nprot.2006.2</ArticleId>
            <ArticleId IdType="pubmed">17406205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou J., Storm D.R., Xia Z. Conditional deletion of ERK5 MAP kinase in the nervous system impairs pheromone information processing and pheromone-evoked behaviors. PLoS ONE. 2013;8:e76901.  doi: 10.1371/journal.pone.0076901.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0076901</ArticleId>
            <ArticleId IdType="pmc">PMC3793934</ArticleId>
            <ArticleId IdType="pubmed">24130808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Razzoli M., Nyuyki-Dufe K., Gurney A., Erickson C., McCallum J., Spielman N., Marzullo M., Patricelli J., Kurata M., Pope E.A., et al.  Social stress shortens lifespan in mice. Aging Cell. 2018;17:e12778. doi: 10.1111/acel.12778.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/acel.12778</ArticleId>
            <ArticleId IdType="pmc">PMC6052478</ArticleId>
            <ArticleId IdType="pubmed">29806171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spinello C., Laviola G., Macrì S. Pediatric Autoimmune Disorders Associated with Streptococcal Infections and Tourette’s Syndrome in Preclinical Studies. Front. Neurosci. 2016;10:310. doi: 10.3389/fnins.2016.00310.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnins.2016.00310</ArticleId>
            <ArticleId IdType="pmc">PMC4928151</ArticleId>
            <ArticleId IdType="pubmed">27445678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swedo S.E., Grant P.J. Annotation: PANDAS: A model for human autoimmune disease. J. Child Psychol. Psychiatry. 2005;46:227–234. doi: 10.1111/j.1469-7610.2004.00386.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1469-7610.2004.00386.x</ArticleId>
            <ArticleId IdType="pubmed">15755299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trifiletti R.R., Packard A.M. Immune mechanisms in pediatric neuropsychiatric disorders. Tourette’s syndrome, OCD, and PANDAS. Child. Adolesc. Psychiatr. Clin. N. Am. 1999;8:767–775. doi: 10.1016/S1056-4993(18)30152-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1056-4993(18)30152-4</ArticleId>
            <ArticleId IdType="pubmed">10553202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lalonde R. The neurobiological basis of spontaneous alternation. Neurosci. Biobehav. Rev. 2002;26:91–104. doi: 10.1016/S0149-7634(01)00041-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0149-7634(01)00041-0</ArticleId>
            <ArticleId IdType="pubmed">11835987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin J., Tombaugh T.N., Zacharko R.M., Anisman H. Alteration of exploration and the response to food associated cues after treatment with pimozide. Pharmacol. Biochem. Behav. 1983;18:235–246. doi: 10.1016/0091-3057(83)90369-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0091-3057(83)90369-6</ArticleId>
            <ArticleId IdType="pubmed">6835981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jaffard R., Mocaer E., Poignant J.-C., Micheau J., Marighetto A., Meunier M., Béracochéa D. Effects of tianeptine on spontaneous alternation, simple and concurrent spatial discrimination learning and on alcohol-induced alternation deficits in mice. Behav. Pharmacol. 1991;2:37–46. doi: 10.1097/00008877-199102000-00006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00008877-199102000-00006</ArticleId>
            <ArticleId IdType="pubmed">11224046</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartolomucci A., Palanza P., Parmigiani S., Pederzani T., Merlot E., Neveu P.J., Dantzer R. Chronic psychosocial stress down-regulates central cytokines mRNA. Brain Res. Bull. 2003;62:173–178. doi: 10.1016/j.brainresbull.2003.09.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainresbull.2003.09.009</ArticleId>
            <ArticleId IdType="pubmed">14698350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ajmone-Cat M.A., D’Urso M.C., di Blasio G., Brignone M.S., De Simone R., Minghetti L. Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells. Brain Behav. Immun. 2016;55:225–235. doi: 10.1016/j.bbi.2015.11.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbi.2015.11.012</ArticleId>
            <ArticleId IdType="pubmed">26593276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ajmone-Cat M.A., Mancini M., De Simone R., Cilli P., Minghetti L. Microglial polarization and plasticity: Evidence from organotypic hippocampal slice cultures. Glia. 2013;61:1698–1711. doi: 10.1002/glia.22550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22550</ArticleId>
            <ArticleId IdType="pubmed">23918452</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alboni S., Maggi L. Editorial: Cytokines as Players of Neuronal Plasticity and Sensitivity to Environment in Healthy and Pathological Brain. Front. Cell. Neurosci. 2016;9:508. doi: 10.3389/fncel.2015.00508.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fncel.2015.00508</ArticleId>
            <ArticleId IdType="pmc">PMC4709412</ArticleId>
            <ArticleId IdType="pubmed">26793060</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dantzer R., O’Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat. Rev. Neurosci. 2008;9:46–56. doi: 10.1038/nrn2297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn2297</ArticleId>
            <ArticleId IdType="pmc">PMC2919277</ArticleId>
            <ArticleId IdType="pubmed">18073775</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Espinosa-Oliva A.M., de Pablos R.M., Villarán R.F., Argüelles S., Venero J.L., Machado A., Cano J. Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol. Aging. 2011;32:85–102. doi: 10.1016/j.neurobiolaging.2009.01.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.01.012</ArticleId>
            <ArticleId IdType="pubmed">19286276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji K.-A., Eu M.Y., Kang S.-H., Gwag B.J., Jou I., Joe E.-H. Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex. Glia. 2008;56:1039–1047. doi: 10.1002/glia.20677.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.20677</ArticleId>
            <ArticleId IdType="pubmed">18381656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kipp M., Norkute A., Johann S., Lorenz L., Braun A., Hieble A., Gingele S., Pott F., Richter J., Beyer C. Brain-region-specific astroglial responses in vitro after LPS exposure. J. Mol. Neurosci. 2008;35:235–243. doi: 10.1007/s12031-008-9057-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12031-008-9057-7</ArticleId>
            <ArticleId IdType="pubmed">18373222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gądek-Michalska A., Spyrka J., Rachwalska P., Tadeusz J., Bugajski J. Influence of chronic stress on brain corticosteroid receptors and HPA axis activity. Pharmacol. Rep. 2013;65:1163–1175. doi: 10.1016/S1734-1140(13)71474-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1734-1140(13)71474-9</ArticleId>
            <ArticleId IdType="pubmed">24399712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizoguchi K., Ishige A., Aburada M., Tabira T. Chronic stress attenuates glucocorticoid negative feedback: Involvement of the prefrontal cortex and hippocampus. Neuroscience. 2003;119:887–897. doi: 10.1016/S0306-4522(03)00105-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0306-4522(03)00105-2</ArticleId>
            <ArticleId IdType="pubmed">12809708</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine S., Strebel R., Wenk E.J., Harman P.J. Suppression of experimental allergic encephalomyelitis by stress. Proc. Soc. Exp. Biol. Med. 1962;109:294–298. doi: 10.3181/00379727-109-27183.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3181/00379727-109-27183</ArticleId>
            <ArticleId IdType="pubmed">14464656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine S., Saltzman A. Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain Behav. Immun. 1987;1:336–341. doi: 10.1016/0889-1591(87)90036-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0889-1591(87)90036-5</ArticleId>
            <ArticleId IdType="pubmed">3502584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine S., Wenk E.J., Muldoon T.N., Cohen S.G. Enhancement of experimental allergic encephalomyelitis by adrenalectomy. Proc. Soc. Exp. Biol. Med. 1962;111:383–385. doi: 10.3181/00379727-111-27799.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3181/00379727-111-27799</ArticleId>
            <ArticleId IdType="pubmed">13930175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Newton R., Shah S., Altonsy M.O., Gerber A.N. Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance. J. Biol. Chem. 2017;292:7163–7172. doi: 10.1074/jbc.R117.777318.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R117.777318</ArticleId>
            <ArticleId IdType="pmc">PMC5409484</ArticleId>
            <ArticleId IdType="pubmed">28283576</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Webster J.C., Oakley R.H., Jewell C.M., Cidlowski J.A. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative isoform: A mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA. 2001;98:6865–6870. doi: 10.1073/pnas.121455098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.121455098</ArticleId>
            <ArticleId IdType="pmc">PMC34444</ArticleId>
            <ArticleId IdType="pubmed">11381138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nair A., Bonneau R.H. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J. Neuroimmunol. 2006;171:72–85. doi: 10.1016/j.jneuroim.2005.09.012.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jneuroim.2005.09.012</ArticleId>
            <ArticleId IdType="pubmed">16278020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi Y.J., Kim H.S., Lee J., Chung J., Lee J.S., Choi J.S., Yoon T.R., Kim H.K., Chung H.Y. Down-regulation of oxidative stress and COX-2 and iNOS expressions by dimethyl lithospermate in aged rat kidney. Arch. Pharm. Res. 2014;37:1032–1038. doi: 10.1007/s12272-014-0332-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12272-014-0332-6</ArticleId>
            <ArticleId IdType="pubmed">24469601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsieh H.-L., Yang C.-M. Role of Redox Signaling in Neuroinflammation and Neurodegenerative Diseases. Biomed. Res. Int. 2013;2013:484613. doi: 10.1155/2013/484613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/484613</ArticleId>
            <ArticleId IdType="pmc">PMC3884773</ArticleId>
            <ArticleId IdType="pubmed">24455696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Madrigal J.L., Moro M.A., Lizasoain I., Lorenzo P., Castrillo A., Boscá L., Leza J.C. Inducible nitric oxide synthase expression in brain cortex after acute restraint stress is regulated by nuclear factor kappaB-mediated mechanisms. J. Neurochem. 2001;76:532–538. doi: 10.1046/j.1471-4159.2001.00108.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1471-4159.2001.00108.x</ArticleId>
            <ArticleId IdType="pubmed">11208916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Novaes L.S., Dos Santos N.B., Dragunas G., Perfetto J.G., Leza J.C., Scavone C., Munhoz C.D. Repeated Restraint Stress Decreases Na,K-ATPase Activity via Oxidative and Nitrosative Damage in the Frontal Cortex of Rats. Neuroscience. 2018;393:273–283. doi: 10.1016/j.neuroscience.2018.09.037.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2018.09.037</ArticleId>
            <ArticleId IdType="pubmed">30316912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong G.H., Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: Possible protective mechanism. Science. 1988;242:941–944. doi: 10.1126/science.3263703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.3263703</ArticleId>
            <ArticleId IdType="pubmed">3263703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Musatov A., Robinson N.C. Susceptibility of mitochondrial electron-transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radic. Res. 2012;46:1313–1326. doi: 10.3109/10715762.2012.717273.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/10715762.2012.717273</ArticleId>
            <ArticleId IdType="pubmed">22856385</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hernández-Aguilera A., Rull A., Rodríguez-Gallego E., Riera-Borrull M., Luciano-Mateo F., Camps J., Menéndez J.A., Joven J. Mitochondrial dysfunction: A basic mechanism in inflammation-related non-communicable diseases and therapeutic opportunities. Mediat. Inflamm. 2013;2013:135698. doi: 10.1155/2013/135698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2013/135698</ArticleId>
            <ArticleId IdType="pmc">PMC3603328</ArticleId>
            <ArticleId IdType="pubmed">23533299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffmann A., Spengler D. The Mitochondrion as Potential Interface in Early-Life Stress Brain Programming. Front. Behav. Neurosci. 2018;12:306. doi: 10.3389/fnbeh.2018.00306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fnbeh.2018.00306</ArticleId>
            <ArticleId IdType="pmc">PMC6291450</ArticleId>
            <ArticleId IdType="pubmed">30574076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Di Filippo M., Chiasserini D., Tozzi A., Picconi B., Calabresi P. Mitochondria and the Link Between Neuroinflammation and Neurodegeneration. J. Alzheimer Dis. 2010;20:S369–S379. doi: 10.3233/JAD-2010-100543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3233/JAD-2010-100543</ArticleId>
            <ArticleId IdType="pubmed">20463396</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Witte M.E., Mahad D.J., Lassmann H., van Horssen J. Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis. Trends Mol. Med. 2014;20:179–187. doi: 10.1016/j.molmed.2013.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molmed.2013.11.007</ArticleId>
            <ArticleId IdType="pubmed">24369898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naik E., Dixit V.M. Mitochondrial reactive oxygen species drive proinflammatory cytokine production. J. Exp. Med. 2011;208:417–420. doi: 10.1084/jem.20110367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20110367</ArticleId>
            <ArticleId IdType="pmc">PMC3058577</ArticleId>
            <ArticleId IdType="pubmed">21357740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park J., Choi H., Min J.-S., Park S.-J., Kim J.-H., Park H.-J., Kim B., Chae J.-I., Yim M., Lee D.-S. Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells. J. Neurochem. 2013;127:221–232. doi: 10.1111/jnc.12361.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jnc.12361</ArticleId>
            <ArticleId IdType="pubmed">23815397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao Y., Zhang X., Shang W., Xu J., Wang X., Hu X., Ao Y., Cheng H. Proinflammatory Cytokines Stimulate Mitochondrial Superoxide Flashes in Articular Chondrocytes In Vitro and In Situ. PLoS ONE. 2013;8:e66444.  doi: 10.1371/journal.pone.0066444.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0066444</ArticleId>
            <ArticleId IdType="pmc">PMC3686682</ArticleId>
            <ArticleId IdType="pubmed">23840469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn W.S., Kuzmicic J., Burrill J.S., Donoghue M.A., Foncea R., Jensen M.D., Lavandero S., Arriaga E.A., Bernlohr D.A. Proinflammatory cytokines differentially regulate adipocyte mitochondrial metabolism, oxidative stress, and dynamics. Am. J. Physiol. Endocrinol. Metab. 2014;306:E1033–E1045. doi: 10.1152/ajpendo.00422.2013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00422.2013</ArticleId>
            <ArticleId IdType="pmc">PMC4010657</ArticleId>
            <ArticleId IdType="pubmed">24595304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Du J., McEwen B., Manji H.K. Glucocorticoid receptors modulate mitochondrial function. Commun. Integr. Biol. 2009;2:350–352. doi: 10.4161/cib.2.4.8554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/cib.2.4.8554</ArticleId>
            <ArticleId IdType="pmc">PMC2734045</ArticleId>
            <ArticleId IdType="pubmed">19721888</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hunter R.G., Seligsohn M., Rubin T.G., Griffiths B.B., Ozdemir Y., Pfaff D.W., Datson N.A., McEwen B.S. Stress and corticosteroids regulate rat hippocampal mitochondrial DNA gene expression via the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA. 2016;113:9099–9104. doi: 10.1073/pnas.1602185113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1602185113</ArticleId>
            <ArticleId IdType="pmc">PMC4987818</ArticleId>
            <ArticleId IdType="pubmed">27457949</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
